339 related articles for article (PubMed ID: 24311633)
1. A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.
Spence T; Perotti C; Sin-Chan P; Picard D; Wu W; Singh A; Anderson C; Blough MD; Cairncross JG; Lafay-Cousin L; Strother D; Hawkins C; Narendran A; Huang A; Chan JA
Neuro Oncol; 2014 Jan; 16(1):62-71. PubMed ID: 24311633
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome 19q13.42 amplification in embryonal brain tumors with ependymoblastic multilayered rosettes.
Nobusawa S; Yokoo H; Hirato J; Kakita A; Takahashi H; Sugino T; Tasaki K; Itoh H; Hatori T; Shimoyama Y; Nakazawa A; Nishizawa S; Kishimoto H; Matsuoka K; Nakayama M; Okura N; Nakazato Y
Brain Pathol; 2012 Sep; 22(5):689-97. PubMed ID: 22324795
[TBL] [Abstract][Full Text] [Related]
3. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Spence T; Sin-Chan P; Picard D; Barszczyk M; Hoss K; Lu M; Kim SK; Ra YS; Nakamura H; Fangusaro J; Hwang E; Kiehna E; Toledano H; Wang Y; Shi Q; Johnston D; Michaud J; La Spina M; Buccoliero AM; Adamek D; Camelo-Piragua S; Peter Collins V; Jones C; Kabbara N; Jurdi N; Varlet P; Perry A; Scharnhorst D; Fan X; Muraszko KM; Eberhart CG; Ng HK; Gururangan S; Van Meter T; Remke M; Lafay-Cousin L; Chan JA; Sirachainan N; Pomeroy SL; Clifford SC; Gajjar A; Shago M; Halliday W; Taylor MD; Grundy R; Lau CC; Phillips J; Bouffet E; Dirks PB; Hawkins CE; Huang A
Acta Neuropathol; 2014 Aug; 128(2):291-303. PubMed ID: 24839957
[TBL] [Abstract][Full Text] [Related]
4. ETMR: a tumor entity in its infancy.
Lambo S; von Hoff K; Korshunov A; Pfister SM; Kool M
Acta Neuropathol; 2020 Sep; 140(3):249-266. PubMed ID: 32601913
[TBL] [Abstract][Full Text] [Related]
5. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
Korshunov A; Ryzhova M; Jones DT; Northcott PA; van Sluis P; Volckmann R; Koster J; Versteeg R; Cowdrey C; Perry A; Picard D; Rosenblum M; Giangaspero F; Aronica E; Schüller U; Hasselblatt M; Collins VP; von Deimling A; Lichter P; Huang A; Pfister SM; Kool M
Acta Neuropathol; 2012 Dec; 124(6):875-81. PubMed ID: 23161096
[TBL] [Abstract][Full Text] [Related]
6. Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Schmidt C; Schubert NA; Brabetz S; Mack N; Schwalm B; Chan JA; Selt F; Herold-Mende C; Witt O; Milde T; Pfister SM; Korshunov A; Kool M
Neuro Oncol; 2017 Nov; 19(12):1607-1617. PubMed ID: 28482026
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Analysis Revealed an Emerging Role of Alternative Splicing in Embryonal Tumor with Multilayered Rosettes.
Hesham D; El-Naggar S
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32971786
[TBL] [Abstract][Full Text] [Related]
8. Intraocular Medulloepitheliomas and Embryonal Tumors With Multilayered Rosettes of the Brain: Comparative Roles of LIN28A and C19MC.
Jakobiec FA; Kool M; Stagner AM; Pfister SM; Eagle RC; Proia AD; Korshunov A
Am J Ophthalmol; 2015 Jun; 159(6):1065-1074.e1. PubMed ID: 25748578
[TBL] [Abstract][Full Text] [Related]
9. Embryonal tumor with multilayered rosettes (ETMR): signed, sealed, delivered ….
Wesseling P
Acta Neuropathol; 2014 Aug; 128(2):305-8. PubMed ID: 25012402
[No Abstract] [Full Text] [Related]
10. Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes.
Dottermusch M; Biabani A; Lempertz T; Schumann Y; Navolic J; Godbole S; Obrecht D; Frank S; Dorostkar MM; Voß H; Schlüter H; Rutkowski S; Schüller U; Neumann JE
Neuro Oncol; 2024 May; 26(5):935-949. PubMed ID: 38158710
[TBL] [Abstract][Full Text] [Related]
11. Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs.
Raghuram N; Khan S; Mumal I; Bouffet E; Huang A
J Neurooncol; 2020 Oct; 150(1):63-73. PubMed ID: 33090313
[TBL] [Abstract][Full Text] [Related]
12. Embryonal tumor with abundant neuropil and true rosettes with only one structure suggestive of an ependymoblastic rosette.
Nobusawa S; Orimo K; Horiguchi K; Ikota H; Yokoo H; Hirato J; Nakazato Y
Pathol Int; 2014 Sep; 64(9):472-7. PubMed ID: 25186165
[TBL] [Abstract][Full Text] [Related]
13. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Korshunov A; Sturm D; Ryzhova M; Hovestadt V; Gessi M; Jones DT; Remke M; Northcott P; Perry A; Picard D; Rosenblum M; Antonelli M; Aronica E; Schüller U; Hasselblatt M; Woehrer A; Zheludkova O; Kumirova E; Puget S; Taylor MD; Giangaspero F; Peter Collins V; von Deimling A; Lichter P; Huang A; Pietsch T; Pfister SM; Kool M
Acta Neuropathol; 2014 Aug; 128(2):279-89. PubMed ID: 24337497
[TBL] [Abstract][Full Text] [Related]
14. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.
Kleinman CL; Gerges N; Papillon-Cavanagh S; Sin-Chan P; Pramatarova A; Quang DA; Adoue V; Busche S; Caron M; Djambazian H; Bemmo A; Fontebasso AM; Spence T; Schwartzentruber J; Albrecht S; Hauser P; Garami M; Klekner A; Bognar L; Montes JL; Staffa A; Montpetit A; Berube P; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel PM; Duchaine T; Perotti C; Fleming A; Faury D; Remke M; Gallo M; Dirks P; Taylor MD; Sladek R; Pastinen T; Chan JA; Huang A; Majewski J; Jabado N
Nat Genet; 2014 Jan; 46(1):39-44. PubMed ID: 24316981
[TBL] [Abstract][Full Text] [Related]
15. Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature.
Ceccom J; Bourdeaut F; Loukh N; Rigau V; Milin S; Takin R; Richer W; Uro-Coste E; Couturier J; Bertozzi AI; Delattre O; Delisle MB
Clin Neuropathol; 2014; 33(1):15-22. PubMed ID: 23863344
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.
Neumann JE; Wefers AK; Lambo S; Bianchi E; Bockstaller M; Dorostkar MM; Meister V; Schindler P; Korshunov A; von Hoff K; Nowak J; Warmuth-Metz M; Schneider MR; Renner-Müller I; Merk DJ; Shakarami M; Sharma T; Chavez L; Glass R; Chan JA; Taketo MM; Neumann P; Kool M; Schüller U
Nat Med; 2017 Oct; 23(10):1191-1202. PubMed ID: 28892064
[TBL] [Abstract][Full Text] [Related]
17. C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.
Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC
Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184
[TBL] [Abstract][Full Text] [Related]
18. Embryonal tumor with multilayered rosettes,
Tauziède-Espariat A; Dufour C; Zerah M; Gareton A; Dangouloff-Ros V; Lechapt E; Boddaert N; Varlet P
Clin Neuropathol; 2021; 40(1):11-16. PubMed ID: 32831158
[TBL] [Abstract][Full Text] [Related]
19. Neuroectodermal Rosettes in Immature Teratomas Are Not the Counterpart of Embryonal Tumours With Multilayered Rosettes.
Magarifuchi N; Yamada Y; Oishi Y; Kato K; Taguchi K; Oda Y
Anticancer Res; 2022 Sep; 42(9):4337-4344. PubMed ID: 36039462
[TBL] [Abstract][Full Text] [Related]
20. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
